找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

1234567
返回列表
打印 上一主題 下一主題

Titlebook: Chronic Lymphocytic Leukemia; Methods and Protocol Sami N. Malek Book 2019 Springer Science+Business Media, LLC, part of Springer Nature 20

[復(fù)制鏈接]
樓主: Philanthropist
61#
發(fā)表于 2025-4-1 05:35:33 | 只看該作者
Ex-Vivo Signal Transduction Studies in Chronic Lymphocytic Leukemia,):2313–2324, 2017). It is important to note that immunoblotting should always be combined with other quantitative methods such as flow cytometry to confirm activation of these signaling pathways (Aguilar-Hernandez et al. Blood 127(24):3015–3025, 2016).
62#
發(fā)表于 2025-4-1 07:26:13 | 只看該作者
The Development and Use of Scalable Systems for Studying Aberrant Splicing in SF3B1-Mutant CLL,ve allowed development of isogenic models and detailed analysis of changes to the transcriptome with relative ease. In this manuscript, we focus on two relevant methods to study splicing factor mutations in CLL: development of isogenic scalable cell lines and informatics analysis of RNA-Seq datasets.
63#
發(fā)表于 2025-4-1 11:24:37 | 只看該作者
64#
發(fā)表于 2025-4-1 16:07:20 | 只看該作者
65#
發(fā)表于 2025-4-1 18:43:27 | 只看該作者
Ex-Vivo Signal Transduction Studies in Chronic Lymphocytic Leukemia,th protein and chemical methods is crucial if we are to investigate and correlate biological changes with therapeutic responses in patients. Herein, we describe the use of western blotting also referred to as immunoblotting as a method that can semiquantitatively evaluate changes in protein expressi
66#
發(fā)表于 2025-4-1 23:08:55 | 只看該作者
Ex Vivo Pharmacological Profiling in Chronic Lymphocytic Leukemia Cells,e the first agent is administered to patients and second drug is tested in these patients’ cells in vitro. These assays have been effective in identifying novel agents that work additively or synergistically. In this chapter, we provide a step-by-step protocol for ex vivo drug testing that can be us
1234567
返回列表
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 00:19
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
墨江| 南昌市| 叶城县| 隆德县| 綦江县| 伊金霍洛旗| 尖扎县| 红原县| 山西省| 芦山县| 宁蒗| 宾阳县| 漳州市| 河西区| 依安县| 邯郸市| 梓潼县| 珲春市| 邻水| 临猗县| 鲜城| 大埔县| 灵寿县| 莱西市| 长寿区| 客服| 时尚| 宽甸| 卢湾区| 东台市| 永善县| 翼城县| 临城县| 灵台县| 甘德县| 宜兰市| 高清| 施甸县| 西城区| 台东县| 贞丰县|